Pricing
Login
Home
Charts
Search
Watchlist
Products

Caplin Point Laboratories Ltd

CAPLIPOINT
₹2,029.10-2.66%20 Nov 2026
Reports
Pharma Formulations

Caplin Point Laboratories Ltd

CAPLIPOINT
₹2,029.10
-2.66%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹15,424Cr
Close
Close Price
₹2,029.10
Industry
Industry
Pharma Formulations
PE
Price To Earnings
22.38
PS
Price To Sales
6.47
Revenue
Revenue
₹2,383Cr
Rev Gr TTM
Revenue Growth TTM
16.84%
PAT Gr TTM
PAT Growth TTM
17.41%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
436453459483493502510534543600610630
Growth YoY
Revenue Growth YoY%
17.116.416.117.813.210.911.210.510.119.419.617.9
Expenses
ExpensesCr
293308307318331334332345353396397407
Operating Profit
Operating ProfitCr
142145152165162168178189190204213223
OPM
OPM%
32.732.033.134.132.933.534.835.435.034.035.035.4
Other Income
Other IncomeCr
171719213126233034283433
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
141616171617161819192223
PBT
PBTCr
145146154168177177184201204213225233
Tax
TaxCr
262529383731344138414650
PAT
PATCr
120121125131140145151160166173179182
Growth YoY
PAT Growth YoY%
23.019.819.912.616.919.820.722.518.419.018.813.8
NPM
NPM%
27.526.827.227.128.428.929.630.030.628.829.328.9
EPS
EPS₹
15.416.016.317.218.318.820.120.321.622.423.323.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
436453459483493502510534543600610630
Growth YoY
Revenue Growth YoY%
17.116.416.117.813.210.911.210.510.119.419.617.9
Expenses
ExpensesCr
293308307318331334332345353396397407
Operating Profit
Operating ProfitCr
142145152165162168178189190204213223
OPM
OPM%
32.732.033.134.132.933.534.835.435.034.035.035.4
Other Income
Other IncomeCr
171719213126233034283433
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
141616171617161819192223
PBT
PBTCr
145146154168177177184201204213225233
Tax
TaxCr
262529383731344138414650
PAT
PATCr
120121125131140145151160166173179182
Growth YoY
PAT Growth YoY%
23.019.819.912.616.919.820.722.518.419.018.813.8
NPM
NPM%
27.526.827.227.128.428.929.630.030.628.829.328.9
EPS
EPS₹
15.416.016.317.218.318.820.120.321.622.423.323.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2394025406498631,0611,2691,4671,6941,9372,1872,383
Growth
Revenue Growth%
68.334.420.233.122.919.615.515.514.412.916.8
Expenses
ExpensesCr
1752773454176037338751,0261,1431,2911,4261,553
Operating Profit
Operating ProfitCr
64124195231260329395441551647761831
OPM
OPM%
26.831.036.135.730.131.031.130.132.533.434.834.9
Other Income
Other IncomeCr
4101319412439566796116129
Interest Expense
Interest ExpenseCr
000002111111
Depreciation
DepreciationCr
71319233237474553667383
PBT
PBTCr
60121188227269314386451564677803875
Tax
TaxCr
1425445054627774103136153175
PAT
PATCr
4696145177215251308377461541650700
Growth
PAT Growth%
108.751.522.121.816.922.722.222.417.320.117.4
NPM
NPM%
19.223.826.827.224.923.724.325.727.227.929.729.4
EPS
EPS₹
6.112.719.223.428.432.039.649.660.270.684.490.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2394025406498631,0611,2691,4671,6941,9372,1872,383
Growth
Revenue Growth%
68.334.420.233.122.919.615.515.514.412.916.8
Expenses
ExpensesCr
1752773454176037338751,0261,1431,2911,4261,553
Operating Profit
Operating ProfitCr
64124195231260329395441551647761831
OPM
OPM%
26.831.036.135.730.131.031.130.132.533.434.834.9
Other Income
Other IncomeCr
4101319412439566796116129
Interest Expense
Interest ExpenseCr
000002111111
Depreciation
DepreciationCr
71319233237474553667383
PBT
PBTCr
60121188227269314386451564677803875
Tax
TaxCr
1425445054627774103136153175
PAT
PATCr
4696145177215251308377461541650700
Growth
PAT Growth%
108.751.522.121.816.922.722.222.417.320.117.4
NPM
NPM%
19.223.826.827.224.923.724.325.727.227.929.729.4
EPS
EPS₹
6.112.719.223.428.432.039.649.660.270.684.490.7
Sales CAGR
1 Year13%
3 Years14%
5 Years16%
TTM17%
EBITDA CAGR
1 Year18%
3 Years20%
5 Years18%
TTM19%
PAT CAGR
1 Year20%
3 Years20%
5 Years21%
TTM17%
Avg. ROCE
1 Year24%
3 Years25%
5 Years27%
TTM22%
CFO / EBITDA
1 Year69%
3 Years65%
5 Years67%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
151515151515151515151515
Reserves
ReservesCr
1132103495147169541,2521,6492,0842,6193,3553,887
Current Liabilities
Current LiabilitiesCr
12511310986144143208268331306386366
Non Current Liabilities
Non Current LiabilitiesCr
142028232517191620152956
Total Liabilities
Total LiabilitiesCr
2673585007431,1261,3641,7362,1912,6983,2084,0454,375
Current Assets
Current AssetsCr
1191793044948231,0151,2981,5521,8932,1342,5862,697
Non Current Assets
Non Current AssetsCr
1491791962493033494396398051,0741,4601,678
Total Assets
Total AssetsCr
2673585007431,1261,3641,7362,1912,6983,2084,0454,375
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
151515151515151515151515
Reserves
ReservesCr
1132103495147169541,2521,6492,0842,6193,3553,887
Current Liabilities
Current LiabilitiesCr
12511310986144143208268331306386366
Non Current Liabilities
Non Current LiabilitiesCr
142028232517191620152956
Total Liabilities
Total LiabilitiesCr
2673585007431,1261,3641,7362,1912,6983,2084,0454,375
Current Assets
Current AssetsCr
1191793044948231,0151,2981,5521,8932,1342,5862,697
Non Current Assets
Non Current AssetsCr
1491791962493033494396398051,0741,4601,678
Total Assets
Total AssetsCr
2673585007431,1261,3641,7362,1912,6983,2084,0454,375

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4268668345269337271318432523
Investing Cash Flow
Investing Cash FlowCr
-6-36-69-100-55-29-377-218-320-335-582
Financing Cash Flow
Financing Cash FlowCr
-14-7-129080-24-41-28-38-38-46
Net Cash Flow
Net Cash FlowCr
2325-147370215-8126-4059-106
Free Cash Flow
Free Cash FlowCr
34431818-3219524678173241275
CFO To PAT
CFO To PAT%
92.670.846.047.320.8106.8109.272.069.079.980.5
CFO To EBITDA
CFO To EBITDA%
66.354.334.136.117.281.785.361.557.766.868.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4268668345269337271318432523
Investing Cash Flow
Investing Cash FlowCr
-6-36-69-100-55-29-377-218-320-335-582
Financing Cash Flow
Financing Cash FlowCr
-14-7-129080-24-41-28-38-38-46
Net Cash Flow
Net Cash FlowCr
2325-147370215-8126-4059-106
Free Cash Flow
Free Cash FlowCr
34431818-3219524678173241275
CFO To PAT
CFO To PAT%
92.670.846.047.320.8106.8109.272.069.079.980.5
CFO To EBITDA
CFO To EBITDA%
66.354.334.136.117.281.785.361.557.766.868.8

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,5282,9334,3323,0432,1363,0575,1534,52910,00415,22211,44115,424
Price To Earnings
Price To Earnings
26.130.729.917.29.912.617.212.021.928.417.822.4
Price To Sales
Price To Sales
6.47.38.04.72.52.94.13.15.97.95.26.5
Price To Book
Price To Book
12.313.111.95.82.93.14.12.74.85.83.44.0
EV To EBITDA
EV To EBITDA
22.822.821.812.57.48.011.99.217.122.614.217.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.447.951.451.048.752.552.651.152.756.056.356.3
OPM
OPM%
26.831.036.135.730.131.031.130.132.533.434.834.9
NPM
NPM%
19.223.826.827.224.923.724.325.727.227.929.729.4
ROCE
ROCE%
46.753.851.842.936.831.930.427.126.925.723.822.4
ROE
ROE%
35.742.539.833.429.425.924.322.722.020.519.317.9
ROA
ROA%
17.126.628.923.819.118.417.817.217.116.916.116.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,5282,9334,3323,0432,1363,0575,1534,52910,00415,22211,44115,424
Price To Earnings
Price To Earnings
26.130.729.917.29.912.617.212.021.928.417.822.4
Price To Sales
Price To Sales
6.47.38.04.72.52.94.13.15.97.95.26.5
Price To Book
Price To Book
12.313.111.95.82.93.14.12.74.85.83.44.0
EV To EBITDA
EV To EBITDA
22.822.821.812.57.48.011.99.217.122.614.217.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.447.951.451.048.752.552.651.152.756.056.356.3
OPM
OPM%
26.831.036.135.730.131.031.130.132.533.434.834.9
NPM
NPM%
19.223.826.827.224.923.724.325.727.227.929.729.4
ROCE
ROCE%
46.753.851.842.936.831.930.427.126.925.723.822.4
ROE
ROE%
35.742.539.833.429.425.924.322.722.020.519.317.9
ROA
ROA%
17.126.628.923.819.118.417.817.217.116.916.116.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr20,46118,27515,97415,42414,89413,84213,196
Close PriceClose₹1,040.951,317.20814.302,029.10935.052,263.20291.15
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE24.2525.6017.7422.3856.2966.8623.56
Price To SalesPS2.415.495.176.471.658.883.89
RevenueRevenueCr8,4773,3303,0892,3839,0121,5593,392
Revenue Growth TTMRev Gr TTM%19.7%11.1%-29.6%16.8%18.3%20.0%24.2%
PAT Growth TTMPAT Gr TTM%32.9%60.0%-56.4%17.4%-44.7%18.3%60.2%
Market CapitalizationMkt CapCr20,46118,27515,97415,42414,89413,84213,196
Close PriceClose₹1,040.951,317.20814.302,029.10935.052,263.20291.15
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE24.2525.6017.7422.3856.2966.8623.56
Price To SalesPS2.415.495.176.471.658.883.89
RevenueRevenueCr8,4773,3303,0892,3839,0121,5593,392
Revenue Growth TTMRev Gr TTM%19.7%11.1%-29.6%16.8%18.3%20.0%24.2%
PAT Growth TTMPAT Gr TTM%32.9%60.0%-56.4%17.4%-44.7%18.3%60.2%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Jun 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
ResultPPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
ResultPPT
Transcript
Summary
Load More
Interviews